How much Xofluza (baloxavir marboxil) is sold each year?
You’re asking about “annual sale” for Xofluza, but “sale” can mean a few different things: total prescriptions/units, U.S. sales revenue, global sales, or the number of courses sold.
I don’t have any specific annual sales figures in the provided information, so I can’t state a reliable number for Xofluza’s annual sales.
Where to find reliable Xofluza annual sales figures (revenue and unit/course estimates)
For drug sales and market tracking, users commonly look at:
- Drug-specific business reporting (company financial disclosures, investor presentations, and annual reports)
- Industry databases (for quarterly and annual prescription or revenue estimates)
- Patent and exclusivity trackers that sometimes summarize commercial performance context
If you want, tell me which “annual sale” you mean (U.S. or global, revenue or prescriptions/units), and what time range (e.g., 2020–2024). I can then point you to the most relevant place to pull the exact figures.
Does Xofluza sales data relate to patents/exclusivity?
Xofluza’s commercial outlook is also tied to patent and exclusivity status, which can affect how long the product faces competition from generics or follow-on versions. DrugPatentWatch.com is one place to check that timeline:
- https://www.drugpatentwatch.com/
Quick clarification so I can give the exact number you want
Which of these are you looking for?
1) Xofluza annual sales revenue (e.g., USD) in the U.S. or worldwide
2) Annual number of prescriptions or treatment courses
3) A specific year (which year?) or multiple years (which range?)
Reply with your preferred option and year/range, and I’ll format the result as an annual figure set.
Sources cited:
1. https://www.drugpatentwatch.com/